Induction of the heregulin-encoding gene NRG1 alters CRC and NSCLC cells harboring an EGFR-activating mutation in such a way that they are resistant to EGFR-targeted agents26,27. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.